𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis and biological evaluation of 14-alkoxymorphinans. Part 7. 14,14′-dimethoxy analogues of norbinaltorphimine: Synthesis and determination of their χ opioid antagonist selectivity

✍ Scribed by Helmut Schmidhammer; Ernst Ganglbauer; Jörg Mitterdorfer; Judith M. Rollinger; Colin F. C. Smith

Publisher
John Wiley and Sons
Year
1990
Tongue
German
Weight
342 KB
Volume
73
Category
Article
ISSN
0018-019X

No coin nor oath required. For personal study only.

✦ Synopsis

R'

📜 SIMILAR VOLUMES

Synthesis and Biological Evaluation of 1
Synthesis and Biological Evaluation of 14-Alkoxymorphinans. Part 9. 14-O-ethyl-5-methylnaltrexone, and opioid antagonist with unusual selectivity
✍ Helmut Schmidhammer; Andrea Schratz; Charlotte Schmidt; Dinesh Patel; John R. Tr 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 German ⚖ 325 KB

Ethyl-5-methylnaloxone (7) and 14-0-ethyl-5-methylnaltrexone (8) have been prepared starting from 14-0-ethyl-5-methyloxycodone (9) in several steps. Both, 7 and 8, were found to be opioid antagonists in vitro and in vivo. Compound 7 exhibited some selectivity forp opioid receptors, whereas compound

Synthesis and Biological Evaluation of 1
Synthesis and Biological Evaluation of 14-Alkoxymorphinans. Part 8. 14-methoxymetopon, an extremely potent opioid agonist
✍ Helmut Schmidhammer; Andrea Schratz; Jörg Mitterdorfer 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 German ⚖ 212 KB

Introduction. -5-Methyloxymorphone ( = 14-hydroxymetopon; 1) was found to possess slightly less opioid-agonist properties than oxymorphone (2) [2]. When compared to the highly potent opioid agonist 14-0-methyloxymorphone (3

Synthesis and Biological Evaluation of 1
Synthesis and Biological Evaluation of 14-Alkoxymorphinans. Part 19 : Effect of 14-O-Benzylation on the Opioid Receptor Affinity and Antagonist Potency of Naltrexone
✍ Falko Schüllner; Ruth Meditz; Roland Krassnig; Günther Morandell; Valery N. Kali 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 German ⚖ 104 KB

## Abstract The 14‐__O__‐benzylnaltrexones **3**–**6** were prepared from naltrexone (**2**) in several steps. The novel compounds were biologically evaluated in radioligand binding and in [^35^S]GTP__γ__S functional assays in comparison to the reference compound naltrexone. In the binding assay, c